How could a non-opioid painkiller improve the lives of people with chronic pain? What makes a non-opioid painkiller safer ...

There are many different medications to help with pain. Drugs in the non-opioid group are non-habit-forming and can address pain in various areas of the body. Non-opioid pain medications provide ...

The availability of suzetrigine may represent a critical step in addressing the nation’s pain management crisis. While questions remain about its cost, adoption, and long-term efficacy, its novel ...

On 30 January 2025, the US Food and Drug Administration (FDA) approved the non-opioid medication suzetrigine (JOURNAVX), which was developed by Vertex Pharmaceuticals for moderate to severe acute ...

UF scientists have developed a compound that safely activates delta opioid receptors, offering pain relief without ...

If benzos and barbies aren't available, then it's down to the muscle relaxants, anticonvulsants and blood-pressure ...

Proposed transaction will raise $50 million in equity capital and enhance a publicly traded biopharmaceutical company focused ...

The opioid crisis has claimed the lives of over half a million Americans since the beginning of the epidemic, a process ...

Vertex continues to capitalize on its leadership in cystic fibrosis (CF) treatments, where its blockbuster drug Trikafta is ...

Pacira Biosciences has authorized a share buyback program of up to $300 million. The developer of non-opioid pain relievers said Thursday the repurchase program replaces a previous $150 million ...